Plus, Vir Biotechnology and GlaxoSmithKline are teaming up to develop an antibody treatment for the flu, Maersk is building carbon-neutral shipping vessels, and Ford is investing $1 billion in EV production in Europe.
Read MorePlus, Disney shares are down even after posting a surprise profit, the Biden administration secured 100 million more doses each of the Moderna and Pfizer COVID-19 vaccines, and Carl Icahn disclosed a stake in Bausch Health.
Read MorePlus, pot stocks are falling, jobless claims came in worse than expected, and Kraft Heinz is selling its nuts businesses to Hormel for $3.35 billion.
Read MorePlus, the WHO recommended AstraZeneca’s COVID-19 vaccine for all adults over age 18, Target is giving employees incentives to get vaccinated, and GM said that a global chip shortage could cut its earnings by up to $2 billion this year.
Read MorePlus, House Democrats released the first round of draft text for part of the $1.9 trillion stimulus package, Eli Lilly shares are down after announcing the resignation of CFO Smiley, and Avaya shares are up after delivering an earnings beat.
Read MorePlus, AstraZeneca is racing to adapt its COVID-19 vaccine after it was found that it offered little protection against the South African variant of the virus, Hyundai and Kia are down after the carmakers said they are not in talks with Apple to build an autonomous car, and Target shares are up after an upgrade.
Read MoreFor most of the past year, any examination of the Pharmaceutical industry begins and ends with COVID-19 vaccines. Literally, of course, this isn’t true; diseases of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. Nonetheless, the massive, immediate impact […]
Read MorePlus, the Labor Department reported nonfarm payrolls rose by just 49,000 in January, GameStop shares are up after Robinhood removed trading restrictions on the stock, and Teradata shares are up more than 32% this morning.
Read MorePlus, ADP said private companies added 174,000 jobs in January, Vaxart shares are down on concerns over a lackluster immune response to its COVID-19 vaccine, and Capri Holdings delivered an earnings beat.
Read MoreBuy Price: $50.00 or better Sell Price: TradersPro Sell Signal Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally. The company’s products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as […]
Read MorePlus, President Biden and congressional Democrats are moving forward with stimulus, Pfizer said it can deliver 200 million doses of its COVID-19 vaccine to the U.S. by May, and Uber is buying Drizly.
Read MorePlus, Novavax said its coronavirus vaccine was shown to be 89.3% effective at preventing the U.K. variant, GameStop is up again, and crypto Dogecoin rose as much as 800% this morning.
Read MorePlus, the Biden administration said it will order 100 million more COVID-19 vaccine shots, Boeing shares are down after it reported a net loss of $11.9 billion, and GM is teaming up with Navistar on a hydrogen-fueled semi truck.
Read MorePlus, Johnson & Johnson delivered an earnings beat, Regeneron said its COVID-19 antibody cocktail appears to be effective as a passive vaccine, and Bed Bath & Beyond got two downgrades this morning.
Read MorePlus, President Biden is pushing Congress to approve a new round of stimulus, Moderna said it’s working on a COVID-19 vaccine booster shot, and AMC has raised enough to avoid bankruptcy in the medium term.
Read More